Objective: To review the dental literature in terms of soft tissue augmentation procedures and their influence on peri-implant health or disease in partially and fully edentulous patients. ginal bone levels at the study endpoints compared to sites without grafting.
number of in vitro and clinical studies demonstrated a critical threshold value of 2-mm mucosal thickness for implant-borne reconstruction and reconstructive materials less discoloration of the soft tissues (Ioannidis et al., 2017; Jung, Sailer, Hammerle, Attin & Schmidlin, 2007; Jung et al., 2008; Thoma, Brandenberg, et al., 2016) , as well as superior aesthetic outcomes compared to implant sites without grafting (Cornelini, Barone & Covani, 2008; Kan, Rungcharassaeng, Morimoto & Lozada, 2009) . Moreover, an increased soft tissue thickness (thick biotype) may decrease the risk of recessions with immediate implants (Evans & Chen, 2008) . Surgical procedures to augment soft tissue volume were therefore recommended in the esthetic zone mainly from an aesthetic point of view and to compensate for volume loss following tooth extraction and implant therapy with immediate or delayed placement protocols (Cosyn, De Bruyn & Cleymaet, 2013; Schneider, Grunder, Ender, Hammerle & Jung, 2011; Thoma, Zeltner, et al., 2016) .
From a biological point of view, no threshold value for a specific soft tissue thickness could be defined according to a recent systematic review (Akcali et al., 2016) . Still, the major goal of implant therapy is to obtain long-term peri-implant health based on stable peri-implant soft tissue dimensions, low bleeding indices, and stable marginal bone levels. In summary, there is a lack of scientific recommendations whether or not to perform surgical procedures for gain of KT and for gain of mucosal thickness to establish peri-implant health and to limit the incidence of peri-implant disease. Neither do clinical suggestions exist for a specific soft tissue transplant to obtain more favorable outcomes. This question can only be answered by (randomized) controlled clinical trials comparing implant sites with and without soft tissue grafting and/or studies comparing different soft tissue transplants and techniques and reported outcome measures assessing peri-implant health.
The objective of this systematic review was to assess the effect of soft tissue grafting procedures to increase either the width of keratinized tissue or the mucosal thickness at dental implant sites in comparison with implant sites without soft tissue grafting procedures or with different grafting materials/transplants in terms of peri-implant health.
| MATERIAL AND METHODS

| Protocol development and eligibility criteria
A detailed protocol was developed and followed according to the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) statement Moher et al., 2009 ).
| PICO questions
Population: systemically healthy patients with dental implants.
Intervention: soft tissue grafting procedures to increase the keratinized tissue or the mucosal thickness at dental implant sites.
Comparison: implant sites without soft tissue grafting procedures or with (a) different grafting materials/transplants. Outcome:
• Primary outcome: peri-implant health measured by a bleeding index or gingival index.
• Secondary outcomes: probing depth values, marginal bone level changes, plaque index, time-point of intervention, type of material.
| Focused questions
In systemically healthy patients with dental implants, what is the effect of soft tissue grafting procedures to increase the width of keratinized and higher marginal bone levels; (ii) for gain of mucosal thickness using autogenous grafts with significantly less marginal bone loss.
K E Y W O R D S
bleeding on probing, complication, dental implant, free gingival graft, gingival index, peri-implant mucositis, peri-implantitis, periodontal probing depth, soft tissue, subepithelial connective tissue graft, systematic review tissue or the mucosal thickness at dental implant sites in comparison with implant sites without soft tissue grafting procedures or with different grafting materials/transplants in terms of peri-implant health?
| Search strategy
An electronic MEDLINE (PubMed) search was performed for controlled clinical studies, including articles published from January 1, 1966 up to July 31, 2016 in the Dental literature. The search was limited to the English, German, and Spanish languages. Additionally, full-text articles of narrative and systematic reviews on similar topics published between January 2011 and July 2016 were obtained. An additional hand search was performed identifying relevant studies by screening these reviews and the reference list of all obtained full-text articles.
| Search terms
The following search terms were applied as follows:
("acellular dermal matrix" OR "dermal matrix allograft" OR "alloderm" OR "keratinized gingiva" OR "keratinized tissue" OR "soft tissue graft" OR "subepithelial connective tissue graft" OR "connective tissue"(MeSH term) OR "free gingival graft" OR "human fibroblastderived dermal substitute" OR "dermagraft" OR "apligraf" OR "collagen matrix" OR "extracellular membrane" OR "gingival autograft" OR "attached gingiva" OR "attached mucosa" OR "keratinized mucosa" OR "soft tissue augmentation" OR "soft tissue transplantation" OR "vestibuloplasty" (MeSH term) OR "ridge augmentation" OR "soft tissue correction" OR "apically positioned flap") AND ("dental implants" (MeSH term) OR "jaw, edentulous, partially" (MeSH term) OR "pontic" (MeSH term) OR "implant sites" OR "bleeding on probing" OR "sulcus bleeding index")
| Inclusion criteria
Clinical publications were considered if all of the following criteria were suitable: (i) human trials with a minimum amount of 10 patients (five per group), (ii) any controlled clinical study (CCT), (iii) follow-up of at least 3 months, (iv) reported outcome measures following the surgical intervention for gain of keratinized tissue or gain of mucosal thickness around dental implants including any peri-implant bleeding index/parameter, and (v) patients needed to have been examined clinically.
| Exclusion criteria
In vitro and preclinical studies, case series, case reports, and reports based on questionnaires, interviews and charts were excluded from the review as well as all studies not meeting the inclusion criteria.
Moreover, studies dealing with treatment of recession defects and increase of keratinized tissue around teeth and soft tissue volume at pontic sites were not considered.
| Selection of studies
Two authors (DT, NN) independently screened the titles derived from the online search based on the inclusion criteria. Disagreements were solved by discussion. Subsequently, the abstracts of the selected titles were obtained and screened for meeting the inclusion criteria. If no abstract was available, the abstract of the printed article was used.
Thereafter, full-text articles of the selected abstracts were obtained. If title and abstract did not provide sufficient information regarding the inclusion criteria, the full text was obtained as well. Again, disagreements were resolved by discussion, and Cohen's Kappa-coefficient was calculated as a measure of agreement between the two readers.
The final selection based on inclusion/exclusion criteria was made for the full-text articles. For this purpose, Material and Methods, Results, and Discussion of these studies were screened by two reviewers (DT, NN) and double-checked. Any questions that came up during the screening were discussed between the authors to aim for consensus. In case potential publications did not report (in detail) on peri-implant bleeding indices/parameters, authors were contacted and asked if they could provide additional data.
| Data extraction and method of analysis
All data were extracted independently by two reviewers (DTH, NN) using data extraction tables. Any disagreements were thereafter discussed to aim for consensus.
Information on the following parameters was extracted as follows: author(s), year of publication, study setting, study design, number of patients, age range, mean age, gender, dropouts, mean follow-up and range, periodontal status, smoking habits, systemic condition, type of intervention (test and control(s)), implant system, number of implants, number of implant failures, implant survival rate, probing depth (PD), bleeding on probing (BOP) or any other bleeding index, plaque index (PlI) or any other gingival index, mid-facial mucosal level (MML), width of keratinized tissue (KT), mucosal thickness (MT), and marginal bone levels (MBL).
The primary outcome included BOP or any other bleeding/gingival index at the follow-up time-point(s). Secondary outcomes were PD, PlI, MML, KT, MT, and MBL (changes).
| Quality assessment
Two reviewers (DT, NN) independently evaluated the methodological quality of all included studies using the Cochrane Collaboration's tool for assessing risk of bias in randomized controlled clinical studies including six domains/questions (Higgins et al., 2011) . The same tool was applied for controlled clinical trials, hereby omitting questions 2, 3, and 4. Again, disagreements were discussed to aim for consensus.
| Statistical analysis
To summarize and compare studies, mean and standard deviation (SD) values (change final baseline and final data) were directly pooled and analyzed with weighted mean differences (WMDs) and 95% confidence intervals (CIs). In case of studies with more than two arms, each intervention was compared against the control group. Study-specific estimates were pooled with both the fixed-and random-effect models (DerSimonian & Laird, 1986) , and the random-effect model results were presented.
Two groups of meta-analyses were performed based on the type of intervention:
• Interventions directed to increase the width of keratinized tissue (KT). The data for the control group were obtained from implants with xenogeneic soft tissue grafting or from implants with maintenance alone (no soft tissue grafting), whereas the test group comprised of the data from groups with autogenous soft tissue grafting procedures. In addition, a subgroup analysis was carried out on the selected outcome variables using the type of control • Interventions directed to augment the mucosal thickness (MT). In that case, the data for the control group were obtained from implants without soft tissue grafting, whereas the test group comprised of the data from groups with grafting procedures.
The statistical heterogeneity among studies was assessed using the Q test according to Dersimonian and Laird as well as the I2 index (Higgins et al., 2003) , thus reporting the percentage of variation in the global estimate that was attributable to heterogeneity (I2 = 25%: low; I2 = 50%: moderate; I2 = 75%: high heterogeneity).
The publication bias was evaluated using Begg′s and Egger′s tests for small-study effects for gingival index change (in case of KT) and for BOP change (in case of MT). A sensitivity analysis of the meta-analysis results was also performed. 
| RESULTS
| Study characteristics
The electronic search identified a total of 2,823 titles (for details refer to Figure 1) . From assessing the titles, 2,579 were excluded after discussion (inter-reader agreement k = 0.75 ± 0.31). The resulting number of abstracts obtained was 244. Of these, 194 were excluded (inter-reader agreement k = 0.67 ± 0.31).
Subsequently, 50 full-text articles were obtained including 20 review articles. The additional hand search provided three more studies for gain of mucosal thickness (Bienz et al., 2017; Cosyn et al., 2016 ; Migliorati, Amorfini, Signori, Biavati & Benedicenti, 2015).
Finally, 10 articles met the inclusion criteria, four articles for gain of keratinized tissue and six publications for gain of mucosal thickness (Table 1) .
| Exclusion of studies
The authors of potentially excluded full texts were contacted to provide, if available, additional data. Reasons for excluding studies (n = 23, see reference list "List of excluded full-text articles and the reason for exclusion") after reading the full texts were as follows: insufficient data (e.g., no clinical parameters obtained/reported [BOP] ; 17 studies), case reports (three), submerged implants (no data on implants) (one), no control group (one), and no soft tissue grafting performed (one) (see list of excluded studies). Table 2 summarizes the results of the quality assessment of the 10 included studies. Four of the included studies were RCTs (Basegmez, Karabuda, Demirel & Yalcin, 2013; Lorenzo et al., 2012; Migliorati et al., 2015; Yoshino, Kan, Rungcharassaeng, Roe & Lozada, 2014) , and the full checklist (Cochrane Collaboration's tool for assessing the risk of bias) was applied, whereas for the remaining six studies (all CCTs), questions 2, 3, and 4 were omitted.
| Quality assessment of the included studies
F I G U R E 1 Search strategy. *For details and reasons for exclusion see Appendix S1 ("List of reviews" and "List of excluded full-text articles and the reason for exclusion")
| Keratinized tissue
The two included RCTs (Basegmez et al., 2012; Lorenzo et al., 2012) had a low risk of bias for all questions (random sequence generation, allocation concealment, blinding of participants and researchers, blinding of outcome assessments, outcome data, reporting). The two CCTs were judged as having an unclear (Buyukozdemir Askin et al., 2015) or high (Roccuzzo, Grasso & Dalmasso, 2016) risk of selection (random sequence generation) bias. There was insufficient information regarding randomization allocation in one study (Buyukozdemir Askin et al., 2015) , whereas in the other study, patients were allocated to a specific treatment according to the clinician's judgment (Roccuzzo et al., 2016) .
Concerning outcome and reporting bias, both CCTs were judged having a low risk.
For group imbalance and radiographic bias, the risks were considered to be low (Buyukozdemir Askin et al., 2015) or unclear (Roccuzzo et al., 2016) . Clinician bias was either unclear (Buyukozdemir Askin et al., 2015) or low (Roccuzzo et al., 2016) . Both did not perform a sample size calculation (Table 2 ).
Further factors that influenced bias were high patient numbers in both and a long follow-up period of 10 years in the latter study (Roccuzzo et al., 2016) . All other included studies had follow-up periods between 6 and 12 months.
No publication bias was observed for GI change (main outcome variable) with the Egger test (p = .450) and with the Begg's test (.308).
| Mucosal thickness
The two included RCTs (Migliorati et al., 2015; Yoshino et al., 2014) were judged as having a low risk for selection bias since a block randomization generated by a statistician or a computergenerated random list was used. Concerning allocation concealment and blinding of researchers, both studies were considered to have an unclear risk since insufficient information was provided.
One study was judged with a low risk, although the procedure did not allow the surgeon to be blinded for the treatment (Migliorati et al., 2015) . Detection, attrition, and reporting bias were of low risk except for the blinding of the outcome assessment (Yoshino et al., 2014) . Here, all data were gathered by a non-blinded single examiner (Yoshino et al., 2014) , and thus, the detection bias was judged as unclear.
The random sequence allocation (selection bias) was judged as high risk in all four CCTs as they did either not explain the reason for the different treatment options (Bianchi & Sanfilippo, 2004) or the patients were divided into the groups upon the clinicians judgment (Bienz et al., 2017; Cosyn et al., 2016; Fenner, Hammerle, Sailer & Jung 2016 ). Attrition and outcome bias were considered to have a low risk of bias in all four studies. Further bias was judged with a low risk (Bianchi & Sanfilippo, 2004; Cosyn et al., 2016) and unclear risk due to a single examiner collecting the data (Fenner et al., 2016) , no sample size calculation, and retrospective study design (Bienz et al., 2017; Fenner et al., 2016) . (Table 2 ).
No publication bias for BOP changes was detected by Begg 's (p > .05) or Egger's tests (p = .767). The sensitivity analyses for this outcome showed that the exclusion of a single study did not substantially alter any estimate.
| Included studies
The 10 studies that met the inclusion criteria are presented in Table 1 .
Four studies were randomized controlled trials (RCTs) published between 2012 and 2014. Five studies were prospective, controlled clinical studies (CCTs), whereas one study was performed as a retrospective CCT (Bienz et al., 2017) . All CCTs were published between 2004 and 2017. The studies were performed at University settings (n = 7) or in private practice (n = 2), whereas one study did not report on the setting. That particular study was designed as a two-center study (Lorenzo et al., 2012) , whereas the remaining nine studies were single-center studies. The observation period and the reported data in all studies were at least 6 months. 2) The randomization was performed at the day of surgery following the raising of a mucosal partial thickness flap/immediately before the application of the graft using a sealed envelope.
A sealed envelope was opened at the beginning of the surgical procedure following local anesthesia. 2) All prespecified outcomes were reported.
All prespecified outcomes were reported.
All prespecified outcomes were reported. All prespecified outcomes were reported. 2)
The procedure did not allow the surgeon to be blinded for the treatment. Loss to follow-up was disclosed (one patient did not comply with the follow-ups).
All expected data are reported.
No dropout.
Losses to follow-up were disclosed (1 patient died; six moved or had severe illness).
Losses to follow-up were disclosed (one died; three unwilling to return for follow-up 
| Keratinized tissue
The four studies (two RCTs, two CCTs) for gain of keratinized tissue reported on a cohort of 234 patients with a mean age of 56.8 (SD 6.7)
years. Fifty-eight percent of the patients were females. No patients dropped out in three studies, whereas one study had a dropout rate of 20% (Roccuzzo et al., 2016) . All patients were systemically and periodontally healthy at the beginning of the investigations except in one study (Basegmez et al., 2012) . In that particular study, patients were included if they presented signs of mucositis. Two studies only included non-smokers, one study light smokers (<10 cigarettes per day; Lorenzo et al., 2012) , and one study did not report on smoking habits (Roccuzzo et al., 2016) . The overall number of implants included in the studies amounted to 276, and no implant loss was reported (100% implant survival rate) in any of the groups and studies. The mean follow-up time was 36 months (range 6-120 months).
Interventions
The 
1) Authors' judgment; 2) Support for judgment. T A B L E 2 (Continued) T A B L E 3 Original data from the included studies. Study characteristics and interventions
Author
Year of publication
Setting
Study design
Interventions
Test group
Control group
1
Control group
Marginal bone level changes
Marginal bone level and the respective changes were reported in one of four studies (Buyukozdemir Askin et al., 2015) , whereas one study reported on final values only (Roccuzzo et al., 2016) . In the first study, for Roccuzzo et al.: C1, no treatment (maintenance without intervention) without residual keratinized tissue (implants were placed within alveolar mucosa); C2, no treatment (maintenance without intervention) with residual keratinized tissue (implants were placed within keratinized tissue). a significant benefit with lower plaque values was observed following the surgical intervention to increase KT (Buyukozdemir Askin et al., 2015; Roccuzzo et al., 2016) , whereas one study reported a significant decrease of the plaque index over time, but no significant difference compared to the untreated control group at baseline and at 12 months (Basegmez et al., 2013) . Meta-analysis for these data indicated sig- These data were derived from one clinical study and a reported observation period of 6 months.
Interventions
Test group
Control group
1
Control group
nificant
| Mucosal thickness
The six studies (two RCTs, four CCTs) reporting on surgical interventions for gain of mucosal thickness included 260 patients with a mean age of 50.5 (±4.6) years (Table 1) . Fifty-three percent of the patients were females. The mean dropout rate was 5% (0% in three studies).
All patients were systemically and periodontally healthy. One study, however, did not report on the general and periodontal health of the patients (Bianchi & Sanfilippo, 2004) . Included patients were smokers of <15 cigarettes per day (Bianchi & Sanfilippo, 2004) , <6 cigarettes per day (Bienz et al., 2017; Fenner et al., 2016; Migliorati et al., 2015) , or were non-smokers (Cosyn et al., 2016; Yoshino et al., 2014) . The overall number of implants assessed amounted to 260 at baseline and 246 at the follow-up examinations. No implants were reported to be lost (100% implant survival rate) in any of the groups and studies. The mean follow-up time was 40.5 months (range 12-86 months).
Interventions
In five studies, immediate implants were placed, whereas in one study, delayed implant placement was performed (Bienz et al., 2017) . The mucosal thickness was increased at implant placement (Bianchi & Sanfilippo, 2004; Migliorati et al., 2015; Yoshino et al., 2014) or >3 months postimplant placement (Bienz et al., 2017; Cosyn et al., 2016; Fenner et al., 2016) . All procedures were therefore performed prior to the insertion of the final reconstructions.
The therapeutic interventions were reported to be indicated as follows: (i) to prevent recessions and compensate for volume deficiency (Cosyn et al., 2016) , (ii) to facilitate tissue adaptation at implant placement (Bianchi & Sanfilippo, 2004) , (iii) for aesthetic purposes and to compensate for volume deficiencies (Bienz et al., 2017; Fenner et al., 2016) , or (iv) not further mentioned (Migliorati et al., 2015; Yoshino et al., 2014) . 
Effect of grafting procedure on peri-implant health
Bleeding on probing Four studies (Bienz et al., 2017; Cosyn et al., 2016; Fenner et al., 2016; Migliorati et al., 2015) 
Probing depth
In five studies, no significant effect after soft tissue volume augmentation was observed, with mean PD values ranging from 2.50 to 3.45 mm (with grafting); from 2.50 to 3.20 mm (without grafting) at baseline to 3.67-4.09 mm (with grafting); 3.20−3.97 mm (without grafting) after a mean of 57 months (Tables 3-5) . One study reported a significant benefit (lower PD values) following an increase in mucosal thickness (Bianchi & Sanfilippo, 2004) . In that particular study, 27% of the test implant sites (immediate implants with soft tissue grafting) as compared to 45% of the control implant sites (without soft tissue grafting) had PD values >3 mm (Bianchi & Sanfilippo, 2004) . Meta-analysis did not reveal any significant differences regarding PD between grafted (autogenous graft) and control groups (no grafting).
Marginal bone level changes
Marginal bone level changes and final values were reported in two of four studies (Migliorati et al., 2015; Yoshino et al., 2014) . Final values were reported in two studies (Fenner et al., 2016; Yoshino et al., 2014; Tables 3-5) . Groups without soft tissue grafting lost significantly more 
Plaque index
Plaque values were assessed in all six of the included studies. None of the studies reported any significant differences between implants sites that had undergone a soft tissue grafting procedure and the respective control (non-grafted) sites. Moreover, plaque index values remained stable independent of any surgical intervention, the timing of soft tissue grafting (at implant placement or staged), and study design (CCT or RCT) with reported mean follow-up periods between 12 and 108 months (Tables 3-5 
| DISCUSSION
The present systematic review assessed the influence of soft tissue grafting procedures on peri-implant health. The outcomes revealed that soft tissue grafting using autogenous tissue for gain of kerati- 
| Keratinized tissue
Various procedures and materials were evaluated in the past to augment keratinized tissue around teeth and dental implants predominantly with the purpose to obtain health of periodontal and peri-implant tissues (Thoma, Benic, Zwahlen, Hammerle & Jung, 2009; Thoma et al., 2014) . BOP and GI values are considered valuable measurements to assess peri-implant health (Heitz-Mayfield, 2008; Salvi & Lang, 2004; Zitzmann & Berglundh, 2008) . These values also serve as indicators for changes of the biological peri-implant environment and the development of peri-implant mucositis, a reversible disease of the peri-implant tissues (Jepsen et al., 2015; Salvi et al., 2012) . In case of increased or increasing BOP and GI values, various surgical techniques were proposed to increase the width of keratinized tissue, thereby establishing peri-implant health and thus preventing the development of peri-implant disease. Data based on the present meta-analyses revealed a significant improvement in the primary outcome BOP/GI over time and significantly lower GI values at the follow-up time-points following grafting with autogenous tissue. Moreover, PD and PlI values decreased, and marginal bone levels were higher for groups with surgical interventions. These results demonstrate that soft tissue grafting procedure results in biologic benefits compared to control groups and thereby justify the surgical interventions. This is in line with previous publications using a retro-or prospective design (Bouri et al., 2008; Schrott et al., 2009 ).
Data from more recent systematic reviews on the topic of keratinized tissue gain around dental implants were more controversial and not able to fully support these surgical interventions to maintain or enhance peri-implant health ( 
| Mucosal thickness
Soft tissue grafting procedures intended to increase the mucosal thickness were predominantly performed to improve the aesthetic outcome and to compensate for existing volume deficiencies (Bienz et al., 2017; Cosyn et al., 2013; Fenner et al., 2016) . Only recently, similar procedures were proposed to target a biologic effect, for example, minimizing marginal bone loss around dental implants (Linkevicius, Puisys, Linkeviciene, Peciuliene & Schlee, 2015 with soft tissue grafting compared to untreated controls. This is in line with short-term results from a clinical study where the presence of a thick (both originally existing and after augmentation with an allograft) peri-implant mucosa led to higher marginal bone levels compared to implant sites with a thin mucosa (Linkevicius et al., 2015) .
Meta-analyses were based on three eligible studies reporting on changes (two studies) and final marginal bone levels (two studies).
These results underline, to some extent, that the data need to be interpreted with caution due to heterogeneity in study design (RCT vs. CCT) and a limited number of included studies. Moreover, the reported borderline significance for final marginal bone levels favoring soft tissue grafting is based on one long-term (7.2-years) study indicating a benefit (Fenner et al., 2016) , and a second study reporting a negative effect (Yoshino et al., 2014) of SCTGs on peri-implant marginal bone levels at a 1-year follow-up. These results were not statistically significant in the original publications, whereas they were borderline significant based on the meta-analysis and must be interpreted with caution due to varying follow-up periods.
| Limitations of the systematic review
The present systematic review covered a new area of research area, and the number of publications found through online, and hand search was therefore limited. The database "MEDLINE" was selected for the electronic search, and thus, the search was based on one database only, although knowing that more databases exist. One might thus speculate that more scientific data exist and might therefore consider this a limitation of the present systematic review. This possible lack was, however, compensated by an additional hand search that included the thorough screening of narrative and systematic review articles, and the, reference lists of all obtained full-text articles even the ones that were later excluded. No further hand search of journals was performed though.
Additionally, the unit of analysis was pooled for the meta-analysis for the sake of the small number of included studies. Although most of the included studies had analyzed their data on the patient level, two studies had used the implant as the unit of analysis. From a methodological point of view, this is an important limitation, as implantlevel analysis tends to underestimate the confidence intervals for the pooled estimate, yielding to an inflated type-I error.
The initial search (limited to one database only and the absence of a grey literature search) provided a relatively high number of potentially eligible studies. Most of these studies, however, did not provide data on bleeding indices, even after contacting the corresponding authors, as their primary focus was aesthetics or changes of marginal bone levels (Cornelini et al., 2008; Grunder, 2011; Linkevicius et al., 2015) . Given these to some extent limited data, clinical recommendations include that in general, the clinician may consider the use of autogenous soft tissue grafting to promote peri-implant soft tissue health or marginal bone levels at implant sites with insufficient soft tissue dimensions. It is anticipated that plaque control is better facilitated in the presence of >2 mm of keratinized tissue. In case an increase of keratinized tissue is desired around a dental implant, the clinician should consider performing a free gingival graft. In the esthetic zone, when an increase in mucosal thickness around implant sites displaying volume deficiencies is desired, clinicians should consider connective tissue grafting procedures to promote greater stability of interproximal marginal bone levels.
| CONCLUSIONS
Soft tissue grafting procedures can be recommended to improve periimplant health. For gain of keratinized tissue, the use of an apically positioned flap in conjunction with autogenous grafts resulted in a greater improvement of bleeding indices and higher marginal bone levels. For gain of mucosal thickness, the use of autogenous grafts resulted in significantly less marginal bone loss over time, but no improvement of further clinical parameters (e.g., bleeding indices).
